<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Recent findings indicate that <z:chebi fb="0" ids="50114">estrogen</z:chebi> (ie, <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> [E(2)]) provides neuroprotection in models of transient global and focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Enhanced postischemic leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and infiltration have been linked to neuropathology in the brain as well as other tissues </plain></SENT>
<SENT sid="2" pm="."><plain>We recently showed that <z:chebi fb="0" ids="50114">estrogen</z:chebi> reduces leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in the cerebral circulation of female rats during resting conditions </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We compared leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in pial venules in vivo in intact, ovariectomized (OVX), and E(2)-treated OVX female rats subjected to transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (30-minute right common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo>) and reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Adherent <z:chebi fb="0" ids="52672">rhodamine-6G</z:chebi>-labeled leukocytes were viewed through a closed cranial window with the use of intravital microscopy </plain></SENT>
<SENT sid="5" pm="."><plain>Leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> was measured before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and at different times after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> (measured as a percentage of venular area occupied by adherent leukocytes) was 2 to 3 times greater in OVX versus intact or E(2)-treated OVX rats (7.0%, 3.4%, and 2.2%, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>This difference disappeared at 120 minutes of reperfusion, when comparable levels of enhanced leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> were observed in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="8" pm="."><plain>In OVX rats, leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> remained elevated after 4 and 6 hours of reperfusion (11.6% and 12.9%, respectively), while the other 2 groups showed significantly lower levels (5.0% and 5.8% for intact rats and 7.0% and 7.2% for E(2)-treated OVX rats) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Present results demonstrate that <z:chebi fb="0" ids="50114">estrogen</z:chebi> modulates leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in the cerebral circulation after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>This effect suggests that decreased leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> may be an important mechanism in <z:chebi fb="0" ids="50114">estrogen</z:chebi>-mediated neuroprotection </plain></SENT>
</text></document>